Protein kinase C beta1 (PKCβ1)

Protein kinase C beta1 is a calcium- and diacylglycerol (DAG)-dependent serine/threonine kinase that plays a central role in intracellular signal transduction and cellular regulation. It phosphorylates a diverse array of protein substrates involved in immunity (e.g., B cell activation), apoptosis, cell proliferation, and metabolic processes. As a conventional PKC isoform, its activation requires both calcium and phosphatidylserine or exogenous phorbol esters. PKCβ1 is implicated in various disease mechanisms including cancer, diabetic retinopathy/edema, and immune disorders. Therapeutic targeting of PKCβ1 primarily involves kinase inhibitors that disrupt its activity and downstream disease-associated signaling.

Other names

PRKCB1PKC-beta 1Protein kinase C, beta 1PKCβPKC-betaProtein kinase C beta IEC 2.7.11PKC-B

PKCβ inhibitors block kinase activity, thereby disrupting PKCβ1-mediated phosphorylation of target proteins and downstream signaling. Drugs may selectively inhibit specific PKCβ isoforms to target pathologic cellular processes (e.g., inflammation, angiogenesis, apoptosis).